Evidence map›Paper›PMID 23608721›Full record

Trial reportThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2013

A randomized clinical trial of vitamin D supplementation in healthy adolescents.

Melissa S Putman, Sarah A B Pitts, Carly E Milliren, Henry A Feldman, Kristina Reinold, Catherine M Gordon

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01126671 nacompletednot on this map

Clinical Trial of Vitamin D Supplementation in Healthy Adolescents

TypeinterventionalSponsorBoston Children's HospitalRan2008 to 2011Enrolled56ConditionsVitamin D SupplementationArmsSupplemental Vitamin D
NCT02301520 completednot on this mapstarted 2015, after this paper: background citation

Vitamin D Deficiency, Iodine Deficiency and Lead Levels in Haitian Infants and Children.

TypeobservationalSponsorBoston Children's HospitalRan2015 to 2015Enrolled299ConditionsVitamin D Deficiency, Iodine Deficiency, Hypothyroidism, Rickets
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Melissa S PutmanDivision of Endocrinology, Department of Medicine, Boston Children's Hospital, Boston, MA, USA. melissa.putman@childrens.harvard.edu
Sarah A B Pitts
Carly E Milliren
Henry A Feldman
Kristina Reinold
Catherine M Gordon
Boston Children's Hospital · US

Funding

Research in Development Endocrinology and MetabolismT32DK007699 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI JOEL N HIRSCHHORN · 1992 to 2026
$7.1M
NCRR NIH HHS UL1 RR 05758NIDDK NIH HHS T32 DK007699NIDDK NIH HHS T32 DK007699-29PHS HHS T71MC00009
6 · The paper itself

Abstract

purposeThe most safe and effective dose of vitamin D supplementation for healthy adolescents is currently unknown. The aim of this study was to compare the efficacy of 200 IU versus 1,000 IU of daily vitamin D3 for supplementation in healthy adolescents with baseline vitamin D sufficiency.

methodsWe conducted a double-blind, randomized clinical trial. Fifty-six subjects, ages 11-19 years, with baseline vitamin D sufficiency received 1,000 IU or 200 IU of daily vitamin D3 for 11 weeks. Compliance was assessed using MEMS6 Trackcaps and pill counts.

resultsFifty-three subjects completed the clinical trial. Subjects in the two treatment arms were similar in terms of age, race, gender, body mass index, and dietary calcium and vitamin D intake. Serum 25(OH)D level in the 200 IU treatment arm was 28.1 ± 6.2 ng/mL at baseline (mean ± SD) and 28.9 ± 7.0 ng/mL at follow-up. In the 1,000 IU treatment arm, 25(OH)D levels were 29.0 ± 7.3 and 30.1 ± 6.6 at baseline and follow-up, respectively. Mean change in 25(OH)D level did not differ significantly between treatment arms (p = .87), nor did mean change in parathyroid hormone, calcium, phosphate, bone turnover markers, fasting glucose, or fasting insulin.

conclusionsIn healthy adolescents with baseline vitamin D sufficiency, supplementation with vitamin D3 doses of 200 and 1,000 IU for 11 weeks did not increase serum 25(OH)D levels, with no significant difference observed between treatment arms.

Indexed as

AdolescentBostonChildDietary SupplementsDouble-Blind MethodFemaleHumansMaleMedication AdherenceTreatment OutcomeVitamin DVitamin D DeficiencyYoung AdultVitamin D

Identifiers

PMID23608721
PMCPMC3634127
OpenAlexW1998296516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.